132 related articles for article (PubMed ID: 17518773)
1. The expression of CD23 and CD40 in primary cutaneous B-cell lymphomas.
Magro C
J Cutan Pathol; 2007 Jun; 34(6):461-6. PubMed ID: 17518773
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study.
Linderoth J; Jerkeman M; Cavallin-Ståhl E; Kvaløy S; Torlakovic E;
Clin Cancer Res; 2003 Feb; 9(2):722-8. PubMed ID: 12576441
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
Magro CM; Dyrsen ME
J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
[TBL] [Abstract][Full Text] [Related]
4. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia.
Lopez-Matas M; Rodriguez-Justo M; Morilla R; Catovsky D; Matutes E
Haematologica; 2000 Nov; 85(11):1140-5. PubMed ID: 11064465
[TBL] [Abstract][Full Text] [Related]
5. CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma.
Dunphy CH; Wheaton SE; Perkins SL
Mod Pathol; 1997 Aug; 10(8):818-22. PubMed ID: 9267825
[TBL] [Abstract][Full Text] [Related]
6. Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma.
Gong JZ; Lagoo AS; Peters D; Horvatinovich J; Benz P; Buckley PJ
Am J Clin Pathol; 2001 Dec; 116(6):893-7. PubMed ID: 11764079
[TBL] [Abstract][Full Text] [Related]
7. CD23 expression in mediastinal large B-cell lymphomas.
Calaminici M; Piper K; Lee AM; Norton AJ
Histopathology; 2004 Dec; 45(6):619-24. PubMed ID: 15569053
[TBL] [Abstract][Full Text] [Related]
8. Use of CD23 (BU38) on paraffin sections in the diagnosis of small lymphocytic lymphoma and mantle cell lymphoma.
Kumar S; Green GA; Teruya-Feldstein J; Raffeld M; Jaffe ES
Mod Pathol; 1996 Sep; 9(9):925-9. PubMed ID: 8878025
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
[TBL] [Abstract][Full Text] [Related]
10. CD2 is expressed by a subpopulation of normal B cells and is frequently present in mature B-cell neoplasms.
Kingma DW; Imus P; Xie XY; Jasper G; Sorbara L; Stewart C; Stetler-Stevenson M
Cytometry; 2002 Oct; 50(5):243-8. PubMed ID: 12360573
[TBL] [Abstract][Full Text] [Related]
11. Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature.
Magro CM; Yang A; Fraga G
Am J Dermatopathol; 2013 May; 35(3):319-26. PubMed ID: 23190506
[TBL] [Abstract][Full Text] [Related]
12. The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma.
Salama ME; Rajan Mariappan M; Inamdar K; Tripp SR; Perkins SL
Int J Surg Pathol; 2010 Apr; 18(2):121-8. PubMed ID: 19223373
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid inhibits CD40 plus IL-4 mediated IgE production through alterations of sCD23, sCD54 and IL-6 production.
Scheffel F; Heine G; Henz BM; Worm M
Inflamm Res; 2005 Mar; 54(3):113-8. PubMed ID: 15883744
[TBL] [Abstract][Full Text] [Related]
14. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group.
Senff NJ; Willemze R
Br J Dermatol; 2007 Dec; 157(6):1205-11. PubMed ID: 17941944
[TBL] [Abstract][Full Text] [Related]
15. Expression of TCL1 and CD27 in primary cutaneous B-cell lymphomas.
Pescarmona E; Remotti D; Perez M; Monaco S; Pacchiarotti A; Faraggiana T; Russo G; Baroni CD
Histopathology; 2006 Oct; 49(4):343-8. PubMed ID: 16978196
[TBL] [Abstract][Full Text] [Related]
16. TCL1 in B-cell tumors retains its normal b-cell pattern of regulation and is a marker of differentiation stage.
Herling M; Patel KA; Hsi ED; Chang KC; Rassidakis GZ; Ford R; Jones D
Am J Surg Pathol; 2007 Jul; 31(7):1123-9. PubMed ID: 17592280
[TBL] [Abstract][Full Text] [Related]
17. Abnormal AP-1 protein expression in primary cutaneous B-cell lymphomas.
Mao X; Orchard G
Br J Dermatol; 2008 Jul; 159(1):145-51. PubMed ID: 18460027
[TBL] [Abstract][Full Text] [Related]
18. Comparison of CD23 staining patterns in Merkel cell carcinoma and non-cutaneous small cell carcinoma.
Carvalho J; Fullen D; Lowe L; Su L; Ma L
J Cutan Pathol; 2009 Feb; 36(2):206-10. PubMed ID: 18616759
[TBL] [Abstract][Full Text] [Related]
19. Diminished expression of CD19 in B-cell lymphomas.
Yang W; Agrawal N; Patel J; Edinger A; Osei E; Thut D; Powers J; Meyerson H
Cytometry B Clin Cytom; 2005 Jan; 63(1):28-35. PubMed ID: 15624204
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]